Pfizer Inc said on Friday its cancer drug Ibrance did not meet the main goal in a late-stage trial in patients with a type of breast cancer, the latest setback in the company's attempt to expand the use of the drug to treat early stages of the disease.
- Pfizer Inc said on Friday its cancer drug Ibrance did not meet the main goal in a late-stage trial in patients with a type of breast cancer, the latest setback in the company’s attempt to expand the use of the drug to treat early stages of the disease.
Ibrance is already approved in the United States to treat certain adult patients with advanced breast cancer which has spread to other parts of the body. The drug has not yet been approved for treating early stages of the disease.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Olivia Newton-John on Kelly Preston's 'Private' Battle With CancerThe actress also opened up on how John Travolta has been healing in the wake of his wife's death.
Read more »
23 Products to Shop Now and Support Breast Cancer AwarenessRalph Lauren, Estée Lauder, Jimmy Choo, and more are donating to help find a cure.
Read more »
23 Products to Shop Now and Support Breast Cancer AwarenessRalph Lauren, Estée Lauder, Jimmy Choo, and more are donating to help find a cure.
Read more »
There Was A Huge Difference In The Way Kamala Harris And Mike Pence Addressed Healthcare In The Debate'If you have a preexisting condition, heart disease, diabetes, breast cancer, they're coming for you,' Harris said.
Read more »
Type 2 diabetes drug manufacturer recalls 76 more lots of metformin for cancer-causing concernsSome of the lots contain N-Nitrosodimethylamine in higher levels that is more than the daily recommended amount. However, it might be safer to keep taking them than to quit cold turkey
Read more »